CD44v6 BiTE expressed from CAdTrio enabled HER2-specific CAR T cells to kill multiple CD44v6+ cancer cell lines and to produce more rapid and sustained disease control of orthotopic HER2+ and HER2− CD44v6+ tumors. The gene discussed is ERBB2; the disease is cancer.